A global player in ophthalmology research

The Institut de la Vision stands out as an essential player on the international stage of ophthalmology research. It is recognized for its major contributions and proven leadership in numerous large-scale global projects.

A strategic partner

The institute plays a pivotal role as a privileged partner or coordinator in multiple large-scale international scientific initiatives, forging close collaborations with the most prestigious research institutions in the world. This international synergy makes it possible to pool expertise and multiply scientific advances in the fight against vision diseases.

Key Figures in 2023





€ 15.5 million 
million in funding 
obtained for projects

International Recognition

The Institut de la Vision's status of excellence has earned it recognition and support from the most reputable funding agencies and foundations worldwide. This trust is a testament to the exceptional quality of the research conducted at the institute and its potential major impact on patients' visual health.

Key Contributions

The Institut de la Vision has made significant contributions to various fields of vision research, including:

  • Gene therapy: pioneering gene therapy approaches to treat inherited retinal diseases. It has notably contributed to bringing new hope for restoring vision in patients with retinal degenerations such as Leber's hereditary optic neuropathy and retinitis pigmentosa;
  • Artificial vision: developing cutting-edge artificial vision systems capable of restoring some degree of vision to people with low vision or blindness. This involves work on retinal implants or artificial retinas, optogenetics, and sonogenetics;
  • Cell therapy: exploring the potential of stem cell therapies for the regeneration of damaged retinal tissues such as retinal pigment epithelium (RPE) cells or photoreceptors ;
  • Imaging and Photonics: pioneering cutting-edge technologies to activate and control cells in the visual system, observe disease-related changes, and monitor treatment efficacy.

The research conducted at the Institut de la Vision or at the international level is paving the way for the development of promising new therapies and more accurate diagnostic tools.